Conferences
High level Thalassaemia & SCD Healthcare Professionals Summit – 1-2 November 2019
Δεκ 21, 2019
High level Thalassaemia & SCD Healthcare Professionals Summit – 1-2 November 2019
Intensifying its long-standing efforts to provide constructive training to both thalassaemia and other haemoglobinopathy patients and to the specialized physicians working in these fields, TIF has successfully hosted a…
Capacity, Competence & Confidence: Building the three CS for patients’ organizations – 12-13 October 2019
Δεκ 21, 2019
Capacity, Competence & Confidence: Building the three CS for patients’ organizations – 12-13 October 2019
Aiming at the continuous training of patients on issues relevant to the management of thalassaemia and other haemoglobinopathies, as well as the improvement of existing conditions and services provided for…
New and Updated Data on Key Thalassaemia & SCD Pipeline Therapies at the American Society of Hematology (ASH) 2019 Annual Meeting – 7-10 December 2019
Νοε 7, 2019
New and Updated Data on Key Thalassaemia & SCD Pipeline Therapies at the American Society of Hematology (ASH) 2019 Annual Meeting – 7-10 December 2019
Celgene Corporation, Acceleron Pharma, Sangamo Therapeutics & Agios Pharmaceuticals are expected to present new and updated data on the progress of key ongoing therapies for thalassaemia and sickle cell…